, Tracking Stock Market Picks
Enter Symbol:
Array Biopharma Inc. (ARRY) [hlAlert]

up 13.17 %

Array Biopharma Inc. (ARRY) upgraded to Outperform by Leerink Swann

Posted on: Wednesday,  Aug 15, 2012  10:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Array Biopharma Inc. (NASDAQ: ARRY) on 08/15/2012, when the stock price was $5.16.
Since then, Array Biopharma Inc. has gained 13.18% as of 01/15/2016's recent price of $5.84.
If you would have followed this Leerink Swann 's recommendation on ARRY, you would have gained 13.17% of your investment in 1248 days.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/15/2012 10:25 AM Buy
as of 12/31/2012
1 Week up  3.33 %
1 Month down  -4.85 %
3 Months down  -36.30 %
1 YTD down  -27.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2009 9:25 AM Hold
2.85 2.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy